Biopharmaceutics

I. Creation of highly functionalized human serum albumin (HSA) and its application to medicine
I-1. Creation of HSA derivatives targeting disease-specific molecules and their application to treatment for diseases
I-2. Creation of next-generation HSA nanoparticles and evaluation of their usefulness against diseases
I-3. Construction of an efficient drug delivery system for intractable cancer
I-4. Development of next-generation cancer treatments using cancer immune regulators
I-5. Development of HSA-based nucleic acid delivery carrier and its application to treatment for diseases
I-6. Elucidation of the intracellular vesicle trafficking mechanism by cell-penetrating HSA and its application to immunotherapy

II. Development of novel treatment methods for disease using medical gases
II-1. Evaluation of the usefulness of carbon monoxide (CO)-loaded red blood cells for anticancer drug-induced depression
II-2. Evaluation of the usefulness of CO-loaded red blood cells for cancer cachexia and its surrounding environment